Technical420 Site Search

The cannabis sector came down from its highs on Friday as global markets plunged on heightened concerns over higher interest rates.The Nasdaq was the hardest hit and the exchange fell more than 2.5%, while the Dow and S&P 500 dropped more than 2% each.What to Expect Today?This market is poised…

GW Pharmaceuticals (GWPH) shares jumped more than 20% after it reported that it was working with Morgan Stanley after other drug makers approached it to express interest in an acquisition, according to people familiar with the matter.GW is one of the leaders in the cannabis industry. The British biopharmaceutical company…

Insys Therapeutics, Inc. (INSY) is up more than 3% in pre-market trading after the Nasdaq-trade cannabis company reported its financial results for the second quarter, which ended on June 30th.This report comes less than a month after Insys announced that the FDA approved Syndros, an orally administered liquid formulation of…

The state of the global economy has led to a number of the best investors and economists to predict a recession within the next 12 to 18 months.As market volatility continues to increase, investors and money managers will continue to exit the stock market as they look for new investment…

Investors, it is time to set aside some cash! On Wednesday, Zynerba Pharmaceuticals, Inc. (ZYNE) will have its initial public offering (IPO) on the NASDAQ exchange. Zynerba will issue 3,000,000 shares and they will be offered in the $13.00-$15.00 range. The total offering amount is $51.75 million (total expenses are…

Yesterday, Zynerba Pharmaceuticals announced the terms of its upcoming initial public offering (IPO). The Pennsylvania-based company plans to raise $42 million by offering 3 million shares in the $13-$15 range. At the midpoint of the proposed range, it would have a fully diluted market value of $128 million. Shares are…

Investors and financial institutions have been patiently waiting for a cannabis-related company to commence trading on a national exchange like the Nasdaq or New York Stock Exchange. Currently, there are only two cannabis related biotech companies that trade on the Nasdaq. These are GW Pharmaceuticals (GWPH) and INSYS Therapeutics, Inc.…